UNITED STATES

 

 

SECURITIES AND EXCHANGE COMMISSION

 

 

Washington, D.C. 20549

 

 

 

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

 

SUCAMPO PHARMACEUTICALS, INC.

(Name of Issuer)

Class A Common Stock

(Title of Class of Securities)

864909106

(CUSIP Number)

December 31, 2007

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o

Rule 13d-1(b)

o

Rule 13d-1(c)

x

Rule 13d-1(d)

 

Check the following box if a fee is being paid with this statement.  o

 

 


 

 


 

CUSIP No. 864909106

 

 

1.

Names of Reporting Person
S&R TECHNOLOGY HOLDINGS, LLC

 

I.R.S Identification No. of Avbove Person

52-2242847

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

o

 

 

(b)

o

 

 

3.

SEC Use Only

 

 

4.

Citizenship or Place of Organization
Delaware

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power
27,500,802(1)

 

6.

Shared Voting Power
0

 

7.

Sole Dispositive Power
27,500,802(1)

 

8.

Shared Dispositive Power
0

 

 

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
27,500,802(1)

 

 

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o

 

 

11.

Percent of Class Represented by Amount in Row (9)
65.9%

 

 

12.

Type of Reporting Person (See Instructions)
OO

 

 


 (1) Includes 26,191,050 shares of Class B Common Stock of the issuer.  Each share of Class B Common Stock is convertible at any time into one share of Class A Common Stock without further consideration.

 

 

2



 

Item 1.

 

(a)

Name of Issuer
Sucampo Pharmaceuticals, Inc.

 

(b)

Address of Issuer’s Principal Executive Offices
4520 East-West Highway

Suite 300

Bethesda, Maryland  20814

 

Item 2.

 

(a)

Name of Person Filing
S&R Technology Holdings, LLC

 

(b)

Address of Principal Business Office or, if none, Residence
7201 Wisconsin Avenue

Suite 700

Bethesda, MD  20814-8410

 

(c)

Citizenship
Delaware

 

(d)

Title of Class of Securities
Class A
Common Stock

 

(e)

CUSIP Number
864909106

 

 

3



Item 3.

If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

 

Not Applicable

 

Item 4.

Ownership

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 

(a)

Amount beneficially owned:

27,500,802(2)

 

(b)

Percent of class:   

65.9%

 

(c)

Number of shares as to which the person has:

 

 

(i)

Sole power to vote or to direct the vote   

27,500,802(2)

 

 

(ii)

Shared power to vote or to direct the vote    

0

 

 

(iii)

Sole power to dispose or to direct the disposition of   

27,500,802(2)

 

 

(iv)

Shared power to dispose or to direct the disposition of   

0

 

Item 5.

Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following   o.

 

Not Applicable

 

Item 6.

Ownership of More than Five Percent on Behalf of Another Person

Not Applicable

 

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person

Not Applicable

 


(2) See footnote 1 on the cover page to this schedule.

 

 

4



 

Item 8.

Identification and Classification of Members of the Group

Not Applicable

 

Item 9.

Notice of Dissolution of Group

Not Applicable

 

Item 10.

Certification

Not Applicable

 

SIGNATURES

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

 

 

 

 

Dated:  February 14, 2008

S&R Technology Holdings, LLC

 

 

By:

/s/ Sachiko Kuno

Name:

Sachiko Kuno

 

 

 

 

 

 

 

5